Last update 09 May 2025

Lactobacillus plantarum strain 299

Overview

Basic Info

Drug Type
Probiotics
Synonyms
DSM-6595
Target-
Action
modulators
Mechanism
Bacteria replacements, Microbiome modulators
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication
Acute Graft Versus Host DiseaseLeukemiaLymphoma+ [1]
Inactive Indication-
Originator Organization
National Cancer InstituteNational Cancer Institute
Active Organization
The Children's Oncology Group Foundation, Inc.The Children's Oncology Group Foundation, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with Lactobacillus plantarum strain 299
ChiCTR2300077434
/ SuspendedEarly Phase 1IIT
Intervention of Lactobacillus animalis and Lactobacillus plantarum in adjuvant treatment of recurrent respiratory tract infections in children
ChiCTR2300075360
/ SuspendedPhase 1IIT
Clinical study on the application of Lactobacillus plantarum in patients with functional constipation
NCT03057054
/ Active, not recruitingPhase 3IIT
The Effectiveness of Lactobacillus Plantarum (LBP, IND# 17339) in Preventing Acute Graft-Versus-Host Disease (GvHD) in Children Undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)
100 Clinical Results associated with Lactobacillus plantarum strain 299
Login to view more data
100 Translational Medicine associated with Lactobacillus plantarum strain 299
Login to view more data
100 Patents (Medical) associated with Lactobacillus plantarum strain 299
Login to view more data
100 Deals associated with Lactobacillus plantarum strain 299
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Graft Versus Host DiseasePhase 3
United States
The Children's Oncology Group Foundation, Inc.The Children's Oncology Group Foundation, Inc.
30 Apr 2018
Acute Graft Versus Host DiseasePhase 3
Canada
The Children's Oncology Group Foundation, Inc.The Children's Oncology Group Foundation, Inc.
30 Apr 2018
LeukemiaPhase 3
United States
The Children's Oncology Group Foundation, Inc.The Children's Oncology Group Foundation, Inc.
30 Apr 2018
LeukemiaPhase 3
Canada
The Children's Oncology Group Foundation, Inc.The Children's Oncology Group Foundation, Inc.
30 Apr 2018
LymphomaPhase 3
United States
The Children's Oncology Group Foundation, Inc.The Children's Oncology Group Foundation, Inc.
30 Apr 2018
LymphomaPhase 3
Canada
The Children's Oncology Group Foundation, Inc.The Children's Oncology Group Foundation, Inc.
30 Apr 2018
Graft vs Host DiseasePhase 3-
The Children's Oncology Group Foundation, Inc.The Children's Oncology Group Foundation, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT03057054 (CTgov)
Phase 3
Acute Graft Versus Host Disease | Leukemia | Lymphoma
173
Allogeneic Hematopoietic Stem Cell Transplantation+Lactobacillus plantarum strain 299v
(Arm I (Lactobacillus Plantarum, alloHCT))
mpeuatksef = jwmqxgdyhm wmdrdabnwa (htjlxvazky, omzkkjqlpu - bgteoudvrk)
View more
-
17 Jul 2023
Allogeneic Hematopoietic Stem Cell Transplantation
(Arm II (Placebo, alloHCT))
mpeuatksef = fytajyyigc wmdrdabnwa (htjlxvazky, dhhueliztw - dfefdkqdaf)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free